Effect of Sustained-Release Cetylpyridinium Chloride Varnish on Streptococcus Mutans and Lactobacillus in Orthodontic Patients
Sponsor
Hadassah Medical Organization (Other)
Overall Status
Unknown status
CT.gov ID
NCT00416286
Collaborator
(none)
30
Study Details
Study Description
Brief Summary
The purpose of the study is to was to evaluate the anti bacterial efficacy of sustain-release Cetylpyridinium chloride varnish on orthodontic patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
30 participants
Observational Model:
Defined Population
Time Perspective:
Prospective
Official Title:
Phase 1: To Evaluate the Antibacterial Efficacy of Sustained Release Cetylpyridinium Chloride Varnish in Orthodontic Patients
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
12 Years
to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Exclusion Criteria:
- Children under 12y old
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Hadassah Medical Organization
Investigators
- Principal Investigator: Doron Harari, DMD, Orthodontic department, Dental school Hadassah Ein Kerem
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00416286
Other Study ID Numbers:
- 26-23.12.05-HMO-CTIL
- 26-23.12.05
- code: 1371
First Posted:
Dec 27, 2006
Last Update Posted:
Dec 27, 2006
Last Verified:
Dec 1, 2006